SILu^™Mab Stable Isotope-Labeled Monoclonal Antibody Glycan Standard Mouse IgG2b

SILuMab G is produced by a proprietary process to yield ¹⁵N-labeled N-glycans.

Supplied as a frozen solution in phosphate-buffered saline pH 7.5

Package size based on protein content determined by A₂₈₀ using an extinction coefficient (E^0.1%) of 1.4

SILuMab G is ideal for the qualitative and quantitative analysis of glycoprotein glycans, and can be applied to individual glycans or complex mixtures.

This product is licensed under U.S. Patent No. 7,396,688 and foreign counterparts from E. I. du Pont de Nemours and Company. The purchase of this product conveys to the buyer the nontransferable right to use the purchased amount of the product for research and development only, including services for a third party for consideration. The buyer cannot sell or otherwise transfer this product, its components or materials made using this product or its components to a third party. Information about licenses for excluded uses is available from: E. I. du Pont de Nemours and Company; Attn: Associate Director, Commercial Development; DuPont Experimental Station E268; 200 Powdermill Rd.; Wilmington, DE 19803; 1-877-881-9787 (voice), 1-302-695-1437 (fax), licensing@dupont.com.

SILu is a trademark of Sigma-Aldrich Co. LLC